About Pegasparagase Injection Hamsyl 3750 Iu5ml
Capitalize on stellar blood cancer therapy with Pegasparagase Injection Hamsyl 3750 IU/5ml from Emcure-an ace choice for treating Acute Lymphoblastic Leukemia (ALL). This clear solution, boasting a competitive pricing model, is tailored for adults and recommended for single-use via IM/IV administration. Manufactured in India and delivered in a secure vial, Hamsyl presents an enviable efficacy profile and enviable shelf life of 24 months. Trust this antineoplastic prescription formulation to deliver reliable results-each pack contains one 5 ml unit at a strength of 3750 IU/5ml.
Comprehensive Usage and Advanced Features
Pegasparagase Injection Hamsyl 3750 IU/5ml is a prescription-only, single-use antineoplastic treatment for adults with Acute Lymphoblastic Leukemia. The application is via intramuscular or intravenous injection, as directed by a physician. Its clear solution ensures precise dosage, and the robust 5 ml vial packaging supports safe, sterile administration. The product boasts a 24-month shelf life and must be stored at 2-8C to maintain optimum efficacy. Benefit from this advanced solution for effective blood cancer management.
Efficient Logistics with Express Shipping
Experience the convenience of fast, reliable delivery with Pegasparagase Injection Hamsyl 3750 IU/5ml. With express shipping options available, customers can estimate shipment arrival and capitalise on lowest price offers for bulk and international orders. Hamsyl is exported and supplied throughout India and globally, delivering prompt access to high-quality cancer therapy. The main domestic market is India, while main export destinations include leading healthcare markets worldwide.
FAQ's of Pegasparagase Injection Hamsyl 3750 Iu5ml:
Q: How is Pegasparagase Injection Hamsyl 3750 IU/5ml administered?
A: Pegasparagase Injection Hamsyl is administered by a healthcare professional either intramuscularly (IM) or intravenously (IV), depending on your physician's recommendation.
Q: What are the key benefits of using Hamsyl Pegasparagase Injection in blood cancer therapy?
A: Hamsyl Pegasparagase is specifically designed for treating Acute Lymphoblastic Leukemia (ALL), offering targeted, antineoplastic action with reliable efficacy and a long 24-month shelf life.
Q: When should Hamsyl Pegasparagase Injection be used?
A: Hamsyl should be used strictly under the guidance of a healthcare professional, as part of a prescribed regimen for adult patients diagnosed with Acute Lymphoblastic Leukemia.
Q: Where is Pegasparagase Injection Hamsyl 3750 IU/5ml manufactured and distributed from?
A: This product is manufactured by Emcure in India and is supplied both domestically and to international markets, ensuring broad access to quality cancer therapy.
Q: What is the process for storing Pegasparagase Injection Hamsyl?
A: The injection should be stored between 2-8C in its original packaging to preserve its potency and stability throughout its 24-month shelf life.